vs
阿普塔集团（ATR）与ROKU, INC（ROKU）财务数据对比。点击上方公司名可切换其他公司
ROKU, INC的季度营收约是阿普塔集团的1.4倍（$1.4B vs $962.7M），阿普塔集团净利率更高（7.7% vs 5.8%，领先2.0%），ROKU, INC同比增速更快（16.1% vs 13.5%），ROKU, INC自由现金流更多（$106.6M vs $96.9M），过去两年ROKU, INC的营收复合增速更高（25.8% vs 2.6%）
阿普塔集团（AptarGroup, Inc.）是总部位于美国的全球性制造企业，主营消费品分配包装产品及药物给药装置的研发与生产，目前在全球18个国家设有生产运营基地，服务医药、快消等多领域客户。
Roku是美国流媒体技术企业，2002年由安东尼·伍德创立，主营数字媒体播放器、电视硬件生产，流媒体内容分发及平台广告运营。截至2024年覆盖用户达1.45亿，是美国流媒体视频分发领域的市场领导者，业务覆盖澳、加、法、德、英及拉美多国。
ATR vs ROKU — 直观对比
营收规模更大
ROKU
是对方的1.4倍
$962.7M
营收增速更快
ROKU
高出2.6%
13.5%
净利率更高
ATR
高出2.0%
5.8%
自由现金流更多
ROKU
多$9.7M
$96.9M
两年增速更快
ROKU
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $962.7M | $1.4B |
| 净利润 | $74.3M | $80.5M |
| 毛利率 | — | 43.5% |
| 营业利润率 | 11.0% | 4.7% |
| 净利率 | 7.7% | 5.8% |
| 营收同比 | 13.5% | 16.1% |
| 净利润同比 | -26.4% | 326.4% |
| 每股收益（稀释后） | $1.13 | $0.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRROKU
| Q4 25 | $962.7M | $1.4B | ||
| Q3 25 | $961.1M | $1.2B | ||
| Q2 25 | $966.0M | $1.1B | ||
| Q1 25 | $887.3M | $1.0B | ||
| Q4 24 | $848.1M | $1.2B | ||
| Q3 24 | $909.3M | $1.1B | ||
| Q2 24 | $910.1M | $968.2M | ||
| Q1 24 | $915.4M | $881.5M |
净利润ATRROKU
| Q4 25 | $74.3M | $80.5M | ||
| Q3 25 | $127.9M | $24.8M | ||
| Q2 25 | $111.7M | $10.5M | ||
| Q1 25 | $78.8M | $-27.4M | ||
| Q4 24 | $100.9M | $-35.5M | ||
| Q3 24 | $100.0M | $-9.0M | ||
| Q2 24 | $90.5M | $-34.0M | ||
| Q1 24 | $83.1M | $-50.9M |
毛利率ATRROKU
| Q4 25 | — | 43.5% | ||
| Q3 25 | — | 43.4% | ||
| Q2 25 | — | 44.8% | ||
| Q1 25 | — | 43.6% | ||
| Q4 24 | — | 42.7% | ||
| Q3 24 | — | 45.2% | ||
| Q2 24 | — | 43.9% | ||
| Q1 24 | — | 44.1% |
营业利润率ATRROKU
| Q4 25 | 11.0% | 4.7% | ||
| Q3 25 | 14.2% | 0.8% | ||
| Q2 25 | 14.9% | -2.1% | ||
| Q1 25 | 12.8% | -5.7% | ||
| Q4 24 | 14.2% | -3.3% | ||
| Q3 24 | 15.2% | -3.4% | ||
| Q2 24 | 13.8% | -7.4% | ||
| Q1 24 | 12.2% | -8.2% |
净利率ATRROKU
| Q4 25 | 7.7% | 5.8% | ||
| Q3 25 | 13.3% | 2.0% | ||
| Q2 25 | 11.6% | 0.9% | ||
| Q1 25 | 8.9% | -2.7% | ||
| Q4 24 | 11.9% | -3.0% | ||
| Q3 24 | 11.0% | -0.9% | ||
| Q2 24 | 9.9% | -3.5% | ||
| Q1 24 | 9.1% | -5.8% |
每股收益（稀释后）ATRROKU
| Q4 25 | $1.13 | $0.55 | ||
| Q3 25 | $1.92 | $0.16 | ||
| Q2 25 | $1.67 | $0.07 | ||
| Q1 25 | $1.17 | $-0.19 | ||
| Q4 24 | $1.48 | $-0.24 | ||
| Q3 24 | $1.48 | $-0.06 | ||
| Q2 24 | $1.34 | $-0.24 | ||
| Q1 24 | $1.23 | $-0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $409.5M | $2.3B |
| 总债务越低越好 | $1.1B | — |
| 股东权益账面价值 | $2.7B | $2.7B |
| 总资产 | $5.3B | $4.4B |
| 负债/权益比越低杠杆越低 | 0.43× | — |
8季度趋势，按日历期对齐
现金及短期投资ATRROKU
| Q4 25 | $409.5M | $2.3B | ||
| Q3 25 | $264.8M | $2.3B | ||
| Q2 25 | $169.8M | $2.3B | ||
| Q1 25 | $136.8M | $2.3B | ||
| Q4 24 | $226.2M | $2.2B | ||
| Q3 24 | $327.9M | $2.1B | ||
| Q2 24 | $223.9M | $2.1B | ||
| Q1 24 | $201.1M | $2.1B |
总债务ATRROKU
| Q4 25 | $1.1B | — | ||
| Q3 25 | $546.0M | — | ||
| Q2 25 | $535.1M | — | ||
| Q1 25 | $561.2M | — | ||
| Q4 24 | $688.1M | — | ||
| Q3 24 | $822.7M | — | ||
| Q2 24 | $681.5M | — | ||
| Q1 24 | $680.4M | — |
股东权益ATRROKU
| Q4 25 | $2.7B | $2.7B | ||
| Q3 25 | $2.8B | $2.6B | ||
| Q2 25 | $2.7B | $2.6B | ||
| Q1 25 | $2.5B | $2.5B | ||
| Q4 24 | $2.5B | $2.5B | ||
| Q3 24 | $2.5B | $2.5B | ||
| Q2 24 | $2.4B | $2.4B | ||
| Q1 24 | $2.3B | $2.4B |
总资产ATRROKU
| Q4 25 | $5.3B | $4.4B | ||
| Q3 25 | $5.1B | $4.4B | ||
| Q2 25 | $4.9B | $4.3B | ||
| Q1 25 | $4.5B | $4.2B | ||
| Q4 24 | $4.4B | $4.3B | ||
| Q3 24 | $4.6B | $4.3B | ||
| Q2 24 | $4.5B | $4.1B | ||
| Q1 24 | $4.4B | $4.2B |
负债/权益比ATRROKU
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.28× | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.7M | $107.7M |
| 自由现金流经营现金流 - 资本支出 | $96.9M | $106.6M |
| 自由现金流率自由现金流/营收 | 10.1% | 7.6% |
| 资本支出强度资本支出/营收 | 9.0% | 0.1% |
| 现金转化率经营现金流/净利润 | 2.47× | 1.34× |
| 过去12个月自由现金流最近4个季度 | $299.6M | $478.4M |
8季度趋势，按日历期对齐
经营现金流ATRROKU
| Q4 25 | $183.7M | $107.7M | ||
| Q3 25 | $177.6M | $127.6M | ||
| Q2 25 | $126.0M | $109.7M | ||
| Q1 25 | $82.7M | $138.7M | ||
| Q4 24 | $178.2M | $79.3M | ||
| Q3 24 | $229.3M | $68.7M | ||
| Q2 24 | $143.6M | $23.4M | ||
| Q1 24 | $92.3M | $46.7M |
自由现金流ATRROKU
| Q4 25 | $96.9M | $106.6M | ||
| Q3 25 | $114.3M | $126.5M | ||
| Q2 25 | $62.5M | $108.6M | ||
| Q1 25 | $25.9M | $136.8M | ||
| Q4 24 | $112.2M | $76.8M | ||
| Q3 24 | $162.7M | $67.6M | ||
| Q2 24 | $75.4M | $22.5M | ||
| Q1 24 | $16.7M | $46.0M |
自由现金流率ATRROKU
| Q4 25 | 10.1% | 7.6% | ||
| Q3 25 | 11.9% | 10.4% | ||
| Q2 25 | 6.5% | 9.8% | ||
| Q1 25 | 2.9% | 13.4% | ||
| Q4 24 | 13.2% | 6.4% | ||
| Q3 24 | 17.9% | 6.4% | ||
| Q2 24 | 8.3% | 2.3% | ||
| Q1 24 | 1.8% | 5.2% |
资本支出强度ATRROKU
| Q4 25 | 9.0% | 0.1% | ||
| Q3 25 | 6.6% | 0.1% | ||
| Q2 25 | 6.6% | 0.1% | ||
| Q1 25 | 6.4% | 0.2% | ||
| Q4 24 | 7.8% | 0.2% | ||
| Q3 24 | 7.3% | 0.1% | ||
| Q2 24 | 7.5% | 0.1% | ||
| Q1 24 | 8.3% | 0.1% |
现金转化率ATRROKU
| Q4 25 | 2.47× | 1.34× | ||
| Q3 25 | 1.39× | 5.14× | ||
| Q2 25 | 1.13× | 10.45× | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | 1.77× | — | ||
| Q3 24 | 2.29× | — | ||
| Q2 24 | 1.59× | — | ||
| Q1 24 | 1.11× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
ROKU
| Services | $1.2B | 88% |
| Products | $170.9M | 12% |
